Milestone Scientific Inc. (NYSEAMERICAN:MLSS)’s share price rose 12.5% on Monday . The company traded as high as $0.64 and last traded at $0.63, approximately 204,222 shares changed hands during trading. A decline of 23% from the average daily volume of 266,474 shares. The stock had previously closed at $0.56.

Separately, Maxim Group reaffirmed a “buy” rating and set a $1.00 target price on shares of Milestone Scientific in a report on Friday, August 16th.

Milestone Scientific (NYSEAMERICAN:MLSS) last announced its earnings results on Wednesday, August 14th. The medical instruments supplier reported ($0.02) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.02). The business had revenue of $2.26 million for the quarter.

A number of hedge funds have recently made changes to their positions in MLSS. Private Capital Group LLC increased its stake in shares of Milestone Scientific by 678.5% in the second quarter. Private Capital Group LLC now owns 31,139 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 27,139 shares in the last quarter. Commonwealth Equity Services LLC increased its stake in shares of Milestone Scientific by 36.3% in the second quarter. Commonwealth Equity Services LLC now owns 95,122 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 25,310 shares in the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Milestone Scientific in the first quarter worth $39,000. Finally, Vanguard Group Inc. increased its stake in shares of Milestone Scientific by 36.4% in the second quarter. Vanguard Group Inc. now owns 134,487 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 35,886 shares in the last quarter.

About Milestone Scientific (NYSEAMERICAN:MLSS)

Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances.

Further Reading: What is an overbought condition?

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.